4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000129
President and CEO sold 2,404 shares at $33.22 ($79,861)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2022-08-19 | Sale | −2,404 | $33.22 | $79,861 | 2,202,993 | I |
| Open-market sales · 2,404 sh · avg $33.22 · $79,861 | |||||||
Loading xslF345X03/wf-form4_166128769265555.xml…